Alcohol
Volume 20, Issue 3 , Pages 247-256 , April 2000

Gamma-hydroxybutyric acid An evaluation of its rewarding properties in rats and mice

Received 6 May 1998 ,Accepted 29 May 1998.

References 

  1. Bardo MT, Rowlett JK, Harris MJ. Conditioned place preference using opiate and stimulant drugs (a meta-analysis). Neurosci Biobehav Rev. 1995;19:39–51
  2. Beardsley PM, Balster RL, Harris LS. Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate. Psychopharmacology. 1996;127:315–322
  3. Benavides J, Rumigny JF, Bourguignon JJ, Cash C, Wermuth CG, Mandel P, et al. A high affinity, Na+-dependent uptake system for γ-hydroxybutyrate in membrane vesicles prepared from rat brain. J Neurochem. 1982;38:1570–1575a
  4. Benavides J, Rumigny JF, Bourguignon JJ, Cash C, Wermuth CG, Mandel P, et al. High affinity binding site for γ-hydroxybutyric acid in rat brain. Life Sci. 1982;30:953–961b
  5. Biggio G, Cibin M, Diana M, Fadda F, Ferrara SD, Gallimberti L, et al. Suppression of voluntary alcohol intake in rats and alcoholics by γ-hydroxybutyric acid (a non-GABAergic mechanism). In:  Biggio G,  Concas A,  Costa E editor. GABAergic Synaptic Transmission. New York: Raven Press; 1992;p. 281–288
  6. Bozarth MA. Evidence for the rewarding effects of ethanol using the conditioned place preference method. Pharmacol Biochem Behav. 1990;35:485–487
  7. Bozarth MA, Wise RA. Heroin reward is dependent on a dopaminergic substrate. Life Sci. 1981;29:1881–1886
  8. Broughton R, Mamelak M. The treatment of narcolepsy-catalepsy with nocturnal gamma-hydroxybutyrate. Can J Neurol Sci. 1979;6:1–6
  9. Caine SB, Linntz R, Koob GF. Intravenous drug self-administration techniques in animals. In:  Sahgal A editors. Behavioral Neuroscience (A Practical Approach). Oxford: Oxford University Press; 1993;p. 93–115
  10. Carr GD, Fibiger HC, Phillips AG. Conditioned place preference as a measure of drug reward. In:  Liebman JM,  Cooper SJ editor. Oxford Reviews in Psychopharmacology, Vol. 1. Neuropharmachological Basis of Reward. New York: Oxford University Press; 1989;p. 264–319
  11. Cash CD. Gammahydroxybutyrate (an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent). Neurosci Biobehav Rev. 1994;18:291–304
  12. Cash CD, Maitre M, Mandel P. Purification from human brain and some properties of two NADPH-linked aldehyde reductases which reduce succinic semialdehyde to 4-hydroxybutyric acid. J Neurochem. 1979;33:1169–1175
  13. Cheramy A, Nieoullon A, Glowinski J. Stimulating effects of γ-hydroxybutyrate on dopamine release from the caudate nucleus and the substantia nigra of the cat. J Pharmac Exp Ther. 1977;203:283–293
  14. Collu M, Poggiu AS, Pani L, Serra G. Fluoxetine-induced conditioned place preference (a preliminary study). Synapse. 1997;25:309–311
  15. Colombo C, Agabio R, Balaklievskaia N, Diaz G, Lobina C, Reali R, et al. Oral self-administration of γ-hydroxybutyric acid in the rat. Eur J Pharmacol. 1995;285:103–107a
  16. Colombo C, Agabio R, Lobina C, Reali R, Fadda F, Gessa GL. Cross-tolerance to ethanol and γ-hydroxybutyric acid. Eur J Pharmacol. 1995;273:235–238b
  17. Diana M, Mereu G, Mura A, Fadda F, Passino N, Gessa GL. Low doses of γ-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats. Brain Res. 1991;566:208–211
  18. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentration in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA. 1988;85:5274–5278
  19. Fadda F, Argiolas A, Melis MR. Suppression of voluntary ethanol consumption in rats by gamma-butyrolactone. Life Sci. 1983;32:1471–1477
  20. Feigenbaum JJ, Howard SG. Gammahydroxybutyrate is not a GABA agonist. Prog Neurobiol. 1996;50:1–7a
  21. Feigenbaum JJ, Howard SG. Does gamma hydroxybutyrate inhibit or stimulate central DA release?. Int J Neurosci. 1996;88:53–69b
  22. Frederick, S. L., Galloway, G. P., Staggers, F., Stalcup, S. A., & Smith, D. E. (1994). Gamma-hydroxybutyrate: a putative neurotransmitter that is abused and causes physical dependence. In L. S. Harris (Ed), Problems of Drug Dependence (p. 101). National Institute on Drug Abuse Research Monograph 153. Rockville, MD: National Institute on Drug Abuse.
  23. Gallimberti, L., Gentile, N., Cibin, M., Fadda, F., Canton, G., Ferri, M., Ferrara, S. D., & Gessa, G. L. (1989). Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet, 787–789.
  24. Gallimberti L, Ferri M, Ferrara SD, Fadda F, Gessa GL. Gamma-hydroxybutyric acid in the treatment of alcohol dependence (a double-blind study). Alcohol Clin Exp Res. 1992;16:673–676
  25. Gallimberti L, Cibin M, Pagnin P, Sabbion R, Pani PP, Pirastu R, et al. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome. Neuropsychopharmacology. 1993;9:77–81
  26. Galloway GG, Frederick SL, Staggers FE, Gonzales M, Stalcup SA, Smith DE. Gamma-hydroxybutyrate (an emerging drug of abuse that causes physical dependence). Addiction. 1997;92:89–96
  27. Gessa GL, Vargiu L, Crabai F, Boero GC, Caboni F, Camba R. Selective increase of brain dopamine induced by γ-hydroxybutyrate. Life Sci. 1966;5:1921–1930
  28. Gobaille S, Schmidt C, Cupo A, Herbrecht F, Maitre M. Characterization of methionine-enkephalin release in the rat striatum by in vivo dialysis (effects of gamma-hydroxybutyrate on cellular and extracellular methionine-enkephalin levels). Neuroscience. 1994;60:637–648
  29. Hechler V, Gobaille S, Maitre M. Localization studies of γ-hydroxybutyrate receptors in rats striatum and hippocampus. Brain Res Bull. 1989;23:129–135
  30. Hechler V, Gobaille S, Bourguignon J, Maitre M. Extracellular events induced by γ-hydroxybutyrate in striatum (a microdialysis study). J Neurochem. 1991;56:938–944
  31. Howard SG, Feigenbaum JJ. Effect of gamma-hydroxybutyrate on central dopamine release in vivo. Biochem Pharmacol. 1997;53:103–110
  32. Hubner CB, Koob GF. Bromocriptine produces decreases in cocaine self-administration in the rats. Neuropsychopharmacology. 1990;3:101–108
  33. Imperato A, Di Chiara G. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther. 1986;239:219–228
  34. Katz RJ, Gormezano GA. A rapid and inexpensive technique for assessing the reinforcing effects of opiate drugs. Pharmacol Biochem Behav. 1979;11:231–233
  35. Koob G. Drugs of abuse (anatomy, pharmacology and function of reward pathways). TIPS. 1992;13:177–184
  36. Koob G. The reward system and cocaine abuse. In:  Korenman SG,  Barchas JD editor. Biological Basis of Substance Abuse. New York: Oxford University Press; 1993;p. 339–354
  37. Kuzmin A, Zvartau E, Gessa GL, Martellotta MC, Fratta W. The calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav. 1992;41:497–500
  38. Kuzmin A, Semenova S, Ramsey NF, Zvartau EE, Van Ree JM. Modulation of cocaine intravenous self-administration in drug-naive animals by dihydropyridine Ca2+ channel modulators. Eur J Pharmacol. 1996;295:19–25a
  39. Kuzmin AV, Semenova S, Zvartau EE, Van Ree JM. Enhancement of morphine self-administration in drug naive, inbred strains of mice by acute emotional stress. Eur Neuropsychopharmacol. 1996;6:63–68b
  40. Kuzmin AV, Semenova S, Gerrits MAFM, Zvartau EE, Van Ree JM. κ-Opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice. Eur J Pharmacol. 1997;321:265–271
  41. Laborit G, Larcan A, Kind A. Le gamma-hydroxybutyrate en anesthesie neuro-chirurgicale. Neuro-chirurgie. 1962;8:104–107
  42. Lettieri JT, Fung H. Dose-dependent pharmacokinetics and hypnotic effects of sodium γ-hydroxybutyrate in the rat. J Pharmacol Exp Ther. 1979;208:7–11
  43. Maitre M. The γ-hydroxybutyrate signaling system in brain (organization and functional implications). Prog Neurobiol. 1997;51:337–361
  44. Maitre M, Cash CD, Weissmann-Nanopoulos D, Mandel P. Depolarization-evoked release of γ-hydroxybutyrate from rat brain slices. J Neurochem. 1983;41:287–290a
  45. Maitre M, Rumigny JF, Cash CD, Mandel P. Subcellular distribution of γ-hydroxybutyrate binding sites in rats brain (principal localization in the synaptosomal fraction). Biochem Biophys Res Commun. 1983;110:262–265b
  46. Maitre M, Hechler V, Vayer P, Gorbaille S, Cash CD, Schmitt M, et al. A specific γ-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties. J Pharmacol Exp Ther. 1990;255:657–663
  47. Martellotta MC, Kuzmin A, Muglia P, Gessa GL, Fratta W. Effects of the calcium antagonist isradipine on cocaine intravenous self-administration in rats. Psychopharmacology. 1994;113:378–380
  48. Martellotta MC, Kuzmin A, Zvartau E, Cossu G, Gessa GL, Fratta W. Isradipine inhibits nicotine intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav. 1995;52:271–274
  49. Martellotta MC, Cossu G, Fattore L, Gessa GL, Fratta W. Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice. Neuroscience. 1998;85:327–330
  50. Morgenroth VH, Walters JR, Roth RH. Dopaminergic neurons (alteration in the kinetic properties of tyrosine hydroxylase after cessation of impulse flow). Biochem Pharmacol. 1976;25:655–661
  51. Mucha RF, van der Kooy D, O'Shaughnessy M, Bucenieks P. Drug reinforcement studied by the use of place conditioning in rat. Brain Res. 1982;243:91–105
  52. Nelson T, Kaufman E, Kline J, Sokoloff L. The extraneuronal distribution of γ-hydroxybutyrate. J Neurochem. 1981;37:1345–1348
  53. Nissbrandt H, Engberg G. The GABAB-receptor antagonist, CGP 35348, antagonises γ-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice. J Neural Transm. 1996;103:1255–1263
  54. Pulvirenti L, Koob GF. Lisuride reduces intravenous cocaine self-administration in the rats. Pharmacol Biochem Behav. 1994;47:819–822
  55. Reicher AM, Holman EW. Location preference and flavour aversion reinforced by amphetamine in rats. Anim Learn Behav. 1977;5:343–346
  56. Roth RH. Formation and regional distribution of γ-hydroxybutyric acid in mammalian brain. Biochem Pharmacol. 1970;19:3013–3019
  57. Roth RH, Doherty JP, Walters JR. Gamma-hydroxybutyrate (a role in the regulation of central dopaminergic neurons?). Brain Res. 1980;189:556–560
  58. Rumigny JF, Maitre M, Cash CD, Mandel P. Specific and nonspecific succinic semialdehyde reductases from rat brain (isolation and properties). FEBS Lett. 1980;117:111–116
  59. Schechter MD, Calcagnetti DJ. Trends in place preference conditioning with a cross-indexed bibliography (1957–1991). Neurosci Biobehav Rev. 1993;17:21–41
  60. Sethy VH, Roth RH, Walters JR, Marini J, Van Woert MH. Effect of anesthetic doses of gamma-hydroxybutyrate on the acetylcholine content of rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1976;295:9–14
  61. Sherman JE, Roberts T, Roskam SE, Holman EW. Temporal properties of the rewarding and aversive effects of amphetamine in rats. Pharmacol Biochem Behav. 1980;13:597–599
  62. Snead OC. The ontogeny of [3H]gamma-hydroxybutyrate and [3H]GABAB binding sites (relation to the development of experimental absence seizures). Brain Res. 1994;659:147–156
  63. Snead OC. Presynaptic GABAB- and γ-hydroxybutyric acid-mediated mechanisms in generalized absence seizures. Neuropharmacology. 1996;35:359–367
  64. Spano PF, Tagliamonte A, Tagliamonte P, Gessa GL. Stimulation of brain dopamine synthesis by gamma-hydroxybutyrate. J Neurochem. 1971;18:1831–1836
  65. Stell JM, Ryan JM. Gamma-hydroxybutyrate is a new recreational drug that may lead to loss of consciousness. Br Med J. 1996;313:424
  66. Stone TW. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev. 1993;45:309–379
  67. U.S. Food and Drug Administration . Warning about GHB. J Am Med Assoc. 1991;285:1802
  68. Vayer P, Maitre M. γ-Hydroxybutyrate stimulation of the formation of cyclic GMP and inositol phosphates in rat hippocampal slices. J Neurochem. 1989;52:1382–1387
  69. Vayer P, Mandel P, Maitre M. Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci. 1987;41:1547–1557
  70. Vayer P, Ehrhardt JD, Gobaille S, Mandel P, Maitre M. Gamma-hydroxybutyrate distribution and turnover rates in discrete brain regions of the rat. Neurochem Int. 1988;12:53–59
  71. Waldmeier PC, Fehr B. Effects of baclofen and γ-hydroxybutyrate on rat striatal and mesolimbic 5-HT metabolism. Eur J Pharmacol. 1978;49:177–184
  72. Withiers NW, Pulvirenti L, Koob GF, Gillin J. Cocaine abuse and dependence. J Clin Psychopharmacol. 1995;15:63–78

PII: S0741-8329(99)00088-9

Alcohol
Volume 20, Issue 3 , Pages 247-256 , April 2000

Article Tools

* Image Usage & Resolution